Noticias
Noticias
- ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
18.01.2021 / 08:00 - GlobeNewswire - Gene Therapy Leader Katherine High Joins AskBio as President, Therapeutics
12.01.2021 / 16:37 - GlobeNewswire - DalCor Announces Launch of Dalcetrapib Clinical Trial for COVID-19
11.01.2021 / 13:00 - GlobeNewswire - Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from Multiple Phase 1/2 Gene Therapy Studies
08.01.2021 / 15:00 - GlobeNewswire - Achilles Therapeutics Appoints Arjan Roozen as VP, Site Head and General Manager
08.01.2021 / 13:00 - GlobeNewswire - Sarepta Therapeutics Announces Top-line Results for Part 1 of Study 102 Evaluating SRP-9001, its Investigational Gene Therapy for the Treatment of Duchenne Muscular Dystrophy
07.01.2021 / 22:05 - GlobeNewswire - LEXEO Therapeutics Launches with $85 Million Series A Financing to Develop Gene Therapies for Rare and Non-Rare Monogenic Diseases
07.01.2021 / 13:30 - GlobeNewswire - Silence Therapeutics Appoints Michael H. Davidson, MD, to Board of Directors
06.01.2021 / 13:00 - GlobeNewswire - ViGeneron signs global collaboration agreement for ophthalmic gene therapy development
05.01.2021 / 08:00 - GlobeNewswire - In Addition to Addressing COVID Vaccine Shipping and Storage Requirements, Reflect Scientific’s Proprietary Liquid Nitrogen-based Freezers are Continuing to Support Growing Cell and Gene Therapy Market Requirements for Ultra-Low Temperature Processing and Storage
21.12.2020 / 14:00 - GlobeNewswire
Tiempo real